Resultados da pesquisa - ((brain tumor) or (brain tumors)) one trial

1561

Computerized Cognitive Training for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors: A Randomized Controlled Trial

Computerized Cognitive Training for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors: A Randomized Controlled Trial

Por Conklin, Heather M., Ogg, Robert J., Ashford, Jason M., Scoggins, Matthew A., Zou, Ping, Clark, Kellie N., Martin-Elbahesh, Karen, Hardy, Kristina K., Merchant, Thomas E., Jeha, Sima, Huang, Lu, Zhang, Hui
Publicado no J Clin Oncol (2015)

“... of 68 survivors of childhood acute lymphoblastic leukemia (ALL) or brain tumor (BT) with identified...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1562

A proinflammatory diet is associated with inflammatory gene expression among healthy, non-obese adults: Can social ties protect against the risks?

A proinflammatory diet is associated with inflammatory gene expression among healthy, non-obese adults: Can social ties protect against the risks?

Por Padin, Avelina C., Hébert, James R., Woody, Alex, Wilson, Stephanie J., Shivappa, Nitin, Belury, Martha A., Malarkey, William B., Sheridan, John F., Kiecolt-Glaser, Janice K.
Publicado no Brain Behav Immun (2019)

“... blood mononuclear cells for interleukin (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1563

Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease

Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease

Por Lehallier, Benoit, Essioux, Laurent, Gayan, Javier, Alexandridis, Roxana, Nikolcheva, Tania, Wyss-Coray, Tony, Britschgi, Markus
Publicado no JAMA Neurol (2015)

“... for patient stratification in clinical trials or for personalizing existing or potential upcoming therapies...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1564

QLIF-47. HEALTH RELATED QUALITY OF LIFE AND NEUROLOGICAL DETERIORATION FREE SURVIVAL IN INTELLANCE 2/EORTC TRIAL 1410, A RANDOMIZED PHASE II STUDY ON ABT414 IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA

QLIF-47. HEALTH RELATED QUALITY OF LIFE AND NEUROLOGICAL DETERIORATION FREE SURVIVAL IN INTELLANCE 2/EORTC TRIAL 1410, A RANDOMIZED PHASE II STUDY ON ABT414 IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA

Por Clement, Paul, van den Bent, Martin, Eoli, Marica, Sepulveda, Juan Manuel, Walenkamp, Annemiek, Frenel, Jean-Sebastien, Franceschi, Enrico, Weller, Michael, Chinot, Olivier, de Vos, Filip, Whenham, Nicolas, Sanghera, Paul, Looman, Jim, Lee, Ho-Jin, de Geus, Jan-Peter, Nuyens, Sarah, Spruyt, Maarten, Gorlia, Thierry, Coens, Corneel, Golfinopoulos, Vassilis
Publicado no Neuro Oncol (2017)

“... EGFR amplification. ABT-414 is a tumor-specific antibody-drug conjugate (ADC) combining an antibody...”
Obter o texto integral
Obter o texto integral

Artigo

1565

Treatment Results of Major Salivary Gland Cancer by Surgery with or without Postoperative Radiation Therapy

Treatment Results of Major Salivary Gland Cancer by Surgery with or without Postoperative Radiation Therapy

Por Noh, Jae Myoung, Ahn, Yong Chan, Nam, Heerim, Park, Won, Baek, Chung-Hwan, Son, Young-Ik, Jeong, Han-Sin
Publicado em 2010

“.... Seventy-five (79.8%) patients received PORT. PORT volume included primary tumor bed and pathologically...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1566

P09.09 Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas

P09.09 Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas

Por Sahm, F., Korshunov, A., Jones, D. T. W., Paulus, W., Herold-Mende, C., Unterberg, A., Pfister, S. M., Brandner, S., Wick, W., von Deimling, A.
Publicado no Neuro Oncol (2016)

“...-sequencing applying the previously reported brain tumor gene panel. The control group consisted of 53...”
Obter o texto integral
Obter o texto integral

Artigo

1567

P11.19 Glioblastoma cancer stem cells proliferation and cell cycle arrest under TTFields influence

P11.19 Glioblastoma cancer stem cells proliferation and cell cycle arrest under TTFields influence

Por Mazzanti, M, Verduci, I, Cannavale, G, Pyromali, I, Poloni, R, Rampini, D
Publicado no Neuro Oncol (2019)

“...BACKGROUND: Glioblastoma (GBM) is the most aggressive and fastest growing-type among brain tumours...”
Obter o texto integral
Obter o texto integral

Artigo

1568

Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial

Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial

Por Roerink, Megan E., Knoop, Hans, Bredie, Sebastian J. H., Heijnen, Michael, Joosten, Leo A. B., Netea, Mihai G., Dinarello, Charles A., van der Meer, Jos W. M.
Publicado no Trials (2015)

“... interleukin-1, interleukin-6 or tumor necrosis factor. In this study, the clinical usefulness of anakinra...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1569

IMMU-41. IDO1 INCREASES Treg RECRUITMENT INDEPENDENT OF TRYPTOPHAN METABOLISM IN A MODEL OF GLIOBLASTOMA

IMMU-41. IDO1 INCREASES Treg RECRUITMENT INDEPENDENT OF TRYPTOPHAN METABOLISM IN A MODEL OF GLIOBLASTOMA

Por Zhai, Lijie, Qian, Jun, Ladomersky, Erik, Lauing, Kristen, Scholtens, Denise, Lukas, Rimas, Wainwright, Derek
Publicado no Neuro Oncol (2018)

“... in brain tumors, the pharmacological inhibition of IDO1 metabolism has no effect on Treg accumulation...”
Obter o texto integral
Obter o texto integral

Artigo

1570

A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial

A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment...

Por Baselga, José, Costa, Frederico, Gomez, Henry, Hudis, Clifford A, Rapoport, Bernardo, Roche, Henri, Schwartzberg, Lee S, Petrenciuc, Oana, Shan, Minghua, Gradishar, William J
Publicado em 2013

“... review (Response Evaluation Criteria in Solid Tumors 1.1 criteria). Secondary endpoints include overall...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1571

Materia medica for various cancers

Materia medica for various cancers

Por Cho, William C.S.
Publicado em 2012

“... for nasopharyngeal carcinoma -- 14. Evidence-based anticancer materia medica for brain tumors -- 15. Evidence-based...”
Obter o texto integral

Livro

1572

CBMT-34. MODULATING DIETARY TRYPTOPHAN OR GUT MICROBIOTA LEVELS DOES NOT IMPROVE THE EFFICACY OF COMBINED TREATMENT WITH RADIATION, ANTI-PD-1 mAb, AND AN IDO1 ENZYME INHIBITOR IN A MODEL OF GLIOBLASTOMA

CBMT-34. MODULATING DIETARY TRYPTOPHAN OR GUT MICROBIOTA LEVELS DOES NOT IMPROVE THE EFFICACY OF COMBINED TREATMENT WITH RADIATION, ANTI-PD-1 mAb, AND AN IDO1 ENZYME INHIBITOR IN A MODEL OF GLIOBLASTOMA

Por Ladomersky, Erik, Zhai, Lijie, Lauing, Kristen, Qian, Jun, Bell, April, Otto-Meyer, Sebastian, Savoor, Rohan, Wainwright, Derek
Publicado no Neuro Oncol (2019)

“.... Our current study further interrogates the role of non-GBM cell IDO1 and its role in the brain tumor...”
Obter o texto integral
Obter o texto integral

Artigo

1573

Response Activation and Inhibition in Patients With Prolactinomas: An Electrophysiological Study

Response Activation and Inhibition in Patients With Prolactinomas: An Electrophysiological Study

Por Jian Song, Chenglong Cao, Yu Wang, Shun Yao, Shun Yao, Michael P. Catalino, Michael P. Catalino, Deqi Yan, Guozheng Xu, Lianting Ma
Publicado em 2020-07-01

“.... A 64-electrode electroencephalogram (EEG) skullcap was used to record the brain activity in 20 pre...”
Obter o texto integral

Artigo

1574

TGFβ1 Polymorphisms Predict Distant Metastasis–Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy

... TGFβ1 Polymorphisms Predict Distant Metastasis–Free Survival in Patients with Inoperable Non-Small...

Por Yuan, Xianglin, Wei, Qingyi, Komaki, Ritsuko, Liu, Zhensheng, Yang, Ju, Tucker, Susan L., Xu, Ting, Heymach, John V., Lu, Charles, Cox, James D., Liao, Zhongxing
Publicado em 2013

“...) and poor brain MFS (HR = 2.567 [95% CI = 1.155–5.702], P = 0.021) after adjustment for age, sex, race...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1575

P09.32 High therapy compliance in patients treated with Optune® therapy does not depend on demographic data, stage of disease or treatment duration

P09.32 High therapy compliance in patients treated with Optune® therapy does not depend on demographic data, stage of disease or treatment duration

Por Misch, M., Onken, J.
Publicado no Neuro Oncol (2017)

“... to the tumor in the brain. Here we report our experience with TTFields in 30 patients at Charité over the last...”
Obter o texto integral
Obter o texto integral

Artigo

1576

P21.04 Clinical pathway in glioma management; from NOSC (Neuro-Oncology Scientific Club) meetings to bedside practice

P21.04 Clinical pathway in glioma management; from NOSC (Neuro-Oncology Scientific Club) meetings to bedside practice

Por Anvari, K., Fazl Ersi, M., Etemad-Rezaie, H., Nekooie, S., Arbabi, F., Ganjeifar, B., Bidouei, F., Nikkhah, K., Afarid, M., Torabi-Nami, M.
Publicado no Neuro Oncol (2016)

“... interval strategic meetings, tumor-boards, case-discussions as well as publishing neuro-oncology updates...”
Obter o texto integral
Obter o texto integral

Artigo

1577

CADD-49. IDENTIFICATION AND VALIDATION OF AZOLES AS HK2 INHIBITORS IN GLIOBLASTOMA IN VITRO AND IN VIVO

CADD-49. IDENTIFICATION AND VALIDATION OF AZOLES AS HK2 INHIBITORS IN GLIOBLASTOMA IN VITRO AND IN VIVO

Por Agnihotri, Sameer, Mansouri, Sheila, Burrell, Kelly, Li, Mira, Liu, Jeff, Nejad, Romina, Kumar, Sushil, Jalali, Shahrzad, Singh, Sanjay, Vartanian, Alenoush, Xueyu Chen, Eric, Bunda, Severa, Mansouri, Alireza, Aldape, Kenneth, Zadeh, Gelareh
Publicado no Neuro Oncol (2018)

“...BACKGROUND: Hexokinase I and 2 (HK1/HK2) catalyze the first committed step in glucose metabolism...”
Obter o texto integral
Obter o texto integral

Artigo

1578

HOUT-10. SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) TREATMENT IS ASSOCIATED WITH IMPROVED SURVIVAL AMONG ELDERLY PATIENTS DIAGNOSED WITH GLIOBLASTOMA

HOUT-10. SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) TREATMENT IS ASSOCIATED WITH IMPROVED SURVIVAL AMONG ELDERLY PATIENTS DIAGNOSED WITH GLIOBLASTOMA

Por Otto-Meyer, Sebastian, Ladomersky, Erik, Scholtens, Denise, Zhai, Lijie, Lauing, Kristen, Amidei, Christina, Lukas, Rimas, Wainwright, Derek
Publicado no Neuro Oncol (2018)

“...INTRODUCTION: Glioblastoma (GBM) is an incurable primary brain tumor with a median age of diagnosis...”
Obter o texto integral
Obter o texto integral

Artigo

1579

Single‐institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice

Single‐institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice

Por Desjardins, Annick, Herndon, James E., McSherry, Frances, Ravelo, Arliene, Lipp, Eric S., Healy, Patrick, Peters, Katherine B., Sampson, John H., Randazzo, Dina, Sommer, Nicolas, Friedman, Allan H., Friedman, Henry S.
Publicado no Health Sci Rep (2019)

“... at the Preston Robert Tisch Brain Tumor Center investigated treatment patterns, survival, and safety...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1580

AFATINIB IN THE TREATMENT OF METASTATIC AND LOCALLY ADVANCED LUNG ADENOCARCINOMA WITH EGFR MUTATIONS: NEW SIDES STUDIED POSSIBILITIES

AFATINIB IN THE TREATMENT OF METASTATIC AND LOCALLY ADVANCED LUNG ADENOCARCINOMA WITH EGFR MUTATIONS: NEW SIDES STUDIED POSSIBILITIES

Por E. V. Karabina, L. N. Lubchenko, M. M. Davydov
Publicado em 2017-11-01

“.... The results of several randomized trials determined and proved the role of Afatinib, the selective...”
Obter o texto integral

Artigo

[1]
Anterior
71
72
73
74
75
76
77
78
79
80
81
Seguinte
[81]